1. Home
  2. NBIX vs SUI Comparison

NBIX vs SUI Comparison

Compare NBIX & SUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$163.88

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

SUI

Sun Communities Inc.

HOLD

Current Price

$123.69

Market Cap

14.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
SUI
Founded
1992
1975
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
14.8B
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
NBIX
SUI
Price
$163.88
$123.69
Analyst Decision
Strong Buy
Buy
Analyst Count
22
14
Target Price
$180.91
$141.21
AVG Volume (30 Days)
1.1M
786.2K
Earning Date
05-05-2026
04-27-2026
Dividend Yield
N/A
3.54%
EPS Growth
41.95
1426.76
EPS
1.91
N/A
Revenue
$161,626,000.00
$2,306,100,000.00
Revenue This Year
$24.73
$5.24
Revenue Next Year
$13.14
$5.08
P/E Ratio
$87.58
N/A
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$115.53
52 Week High
$169.57
$137.85

Technical Indicators

Market Signals
Indicator
NBIX
SUI
Relative Strength Index (RSI) 65.15 47.83
Support Level $134.92 $119.42
Resistance Level N/A $129.37
Average True Range (ATR) 4.51 3.00
MACD 0.13 -0.00
Stochastic Oscillator 67.18 42.65

Price Performance

Historical Comparison
NBIX
SUI

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About SUI Sun Communities Inc.

Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 513 properties, which includes 347 manufactured housing communities and 166 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties, with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.

Share on Social Networks: